Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.31 |
| ▸ | IKBKB | O14920 | 1/20 | 0.31 |
| ▸ | CDK1 | P06493 | 1/20 | 0.30 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | CDK2 | P24941 | 1/20 | 0.30 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.30 |
| ▸ | GSK3A | P49840 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.30 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28321743 | 0.73 | CYP2A6 (0.38) | GAAMAPK1RAB9ACDK2 | |
| SCHEMBL5612780 | 0.69 | IDO1 (0.54) | GAAMAPK1RAB9A | |
| SCHEMBL16399113 | 0.69 | CTSS (0.36) | IKBKB | |
| SCHEMBL5612882 | 0.67 | KIF11 (0.45) | F2RL3 | |
| SCHEMBL28321645 | 0.65 | ALDH1A1 (0.53) | GAAMAPK1RAB9APIM1CDK5 | |
| SCHEMBL28321731 | 0.64 | NFE2L2 (0.40) | DYRK1A | |
| SCHEMBL26070295 | 0.64 | CTSS (0.34) | — | |
| SCHEMBL16398344 | 0.64 | RXRA (0.34) | CDK1PIM1CDK2MAPKAPK2GSK3A | |
| SCHEMBL28841108 | 0.63 | NR2E1 (0.46) | IKBKB | |
| SCHEMBL28320562 | 0.63 | MAOB (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105408325-B | cyanotriazole compounds | 大塚制药株式会社 | 2019-10-22 | — | — | CN | disclosed |